Cefepime Hydrochloride And Dextrose NDC 0264-3195

NDC codes

FDA NDC Directory

Product NDC (as listed)0264-3195Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00264-3195Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0264-3195-11	00264319511	24 CONTAINER in 1 CASE (0264-3195-11) / 50 mL in 1 CONTAINERMarketed from May 6, 2010

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefepime Hydrochloride And Dextrose
Generic name (nonproprietary): cefepime hydrochloride
Active ingredients: Cefepime hydrochloride — 2 g/50mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: B. Braun Medical Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 050821
Marketing start: May 6, 2010
Listing expires: Dec 31, 2027
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 0264-3195_8b4b5fb9-6be2-40c8-a8ef-60a9d7967e3eSPL ID 8b4b5fb9-6be2-40c8-a8ef-60a9d7967e3eSPL set ID 57517a0e-ec1b-4605-a7cc-7e3801158ec9RxCUI 1665088, 1665093UNII I8X1O0607P
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400264319511 followed by a unit qualifier and the quantity

Package 00264-3195-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 7, 2026.

Indications (excerpt from the label)

Cefepime for Injection and Dextrose Injection is a cephalosporin antibacterial indicated in the treatment of the following infections caused by susceptible strains of the designated microorganisms: Pneumonia ( 1.1 ) Empiric therapy for febrile neutropenic patients ( 1.2 ) Uncomplicated and complicated urinary tract infections ( 1.3 ) Uncomplicated skin and skin structure infections ( 1.4 ) Complicated intra-abdominal infections (used in combination with metronidazole) ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefepime for Injection and Dextrose Injection and other antibacterial drugs, Cefepime for Injection and Dextrose Injection should be…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050821

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050821
Product	Strength	Form · route	Labeler	Product NDC
Cefepime Hydrochloride And Dextrosecefepime hydrochloride	Cefepime hydrochloride 1 g/50mL	Injection, SolutionIntravenous	B. Braun Medical Inc.	0264-3193